Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2006
05/03/2006EP1381358B1 Solid pharmaceutical composition comprising 4'-cyano-trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy-2-methylpropiono- m toluidide and pvp
05/03/2006EP1368381B1 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
05/03/2006EP1368006B1 Novel modified released formulation
05/03/2006EP1363618B1 Pharmaceutical composition for treating multiple sclerosis
05/03/2006EP1355638B1 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
05/03/2006EP1353904B9 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
05/03/2006EP1351954B1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives
05/03/2006EP1346987B1 Benzofuran derivatives and pharmaceutical compositions containing the same
05/03/2006EP1336407B1 Composition containing an angiotensin ii receptor antagonist and a diuretic and its use for the treatment of hypertension
05/03/2006EP1335709B1 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole
05/03/2006EP1313422A4 Non-hormonal vaginal contraceptive
05/03/2006EP1311486B1 Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same
05/03/2006EP1299366B1 Method for producing a phenothiazine granulate with improved properties
05/03/2006EP1289923B1 Epithelial cell cancer drug
05/03/2006EP1289383B1 Primary composition containing a lipophilic bioactive compound
05/03/2006EP1248771B1 Method for preparing hydroxypicolinic acid derivatives
05/03/2006EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
05/03/2006EP1242060B1 Treatment of metastatic disease
05/03/2006EP1235564B1 Triiodomethane thickener conjugates, a method for their production and their use as disinfectant cleaners and hygiene products
05/03/2006EP1235558B1 Compressed tablet composition comprising a nsaid
05/03/2006EP1232748B1 Use of substituted nitrobenzene derivatives for the treatment of diseases caused by bacteria, fungi and viruses
05/03/2006EP1227805B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto
05/03/2006EP1225809B1 Methods for stabilizing liquid nutritional products and products so stabilized
05/03/2006EP1210065B1 Cationic liposome delivery of taxanes to angiogenic blood vessels
05/03/2006EP1209988B1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
05/03/2006EP1208091B1 Benzophenones as inhibitors of reverse transcriptase
05/03/2006EP1194404B1 Inhibitors of aspartyl protease
05/03/2006EP1189611B1 Cancer therapy
05/03/2006EP1188755B1 Acylhydrazine derivatives, process for preparing the same and use thereof
05/03/2006EP1185273B1 Antifungal oral composition containing itraconazole and process for preparing same
05/03/2006EP1153017B1 Bicyclic compounds and their use as integrin receptor ligands
05/03/2006EP1143976B1 Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of hiv infections
05/03/2006EP1139755B1 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
05/03/2006EP1137386B1 Use of triclosan as an antimalarial agent
05/03/2006EP1133489B9 Isonipecotamides for the treatment of integrin-mediated disorders
05/03/2006EP1126863B1 Vascular endothelial growth factor-like protein from orf virus nz10 binds and activates mammalian vegf receptor-2
05/03/2006EP1107813B1 Kit for creating in situ, chemically cross-linked, mechanical barriers or covering structures for vascular puncture sites
05/03/2006EP1104309B1 Co-lyophilized complex comprising a nucleic acid vector and a formulating agent
05/03/2006EP1099692B1 N,n-substituted cyclic amine derivatives
05/03/2006EP1089738B1 Antimicrobial compositions comprising taurolidine, citric acid and sodium citrate
05/03/2006EP1074542B1 Sulfonamide-containing indole compounds
05/03/2006EP1056459B1 Treatment of hiv infections
05/03/2006EP1043021B1 Purine derivatives for the treatment of allergic diseases and systemic lupus erythematosus
05/03/2006EP1003508B1 Antimutagenic agents
05/03/2006EP0971899B1 Hexahydroindenopyridine compounds having antispermatogenic activity
05/03/2006EP0955995B1 Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions
05/03/2006EP0937069B1 Piperazino derivatives as neurokinin antagonists
05/03/2006EP0934326B1 Substituted aminoalkane phosphonic acids
05/03/2006EP0927217B1 Angiogenic inhibitory compounds
05/03/2006EP0901368B1 Dermal penetration enhancers and drug delivery systems involving same
05/03/2006EP0810884B1 Treatment of vascular restenosis with inhaled nitric oxide
05/03/2006EP0804200B1 Use of noribogaine derivatives for treating chemical dependency in mammals
05/03/2006EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides
05/03/2006EP0771794B1 Oxygen-containing heterocyclic compounds
05/03/2006EP0672042B1 Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof
05/03/2006CN2776404Y Chinese herbal medicine plaster for treating cough asthma disease by acupoint compress
05/03/2006CN1768080A Modified gum arabic
05/03/2006CN1768075A Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
05/03/2006CN1768073A Oligosaccharide derivative
05/03/2006CN1768072A Glycolipids derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates
05/03/2006CN1768071A Lipid-regulating agent and use thereof
05/03/2006CN1768069A Novel carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them
05/03/2006CN1768065A Thienopyrimidine compound and use of the same
05/03/2006CN1768064A Thiadibenzoazulene derivatives for the treatment of inflammatory diseases
05/03/2006CN1768061A Pyrazolo[1,5-a][1,3,5]triazine derivatives as cannabinoid receptor ligands
05/03/2006CN1768059A Pyrido [2,3-d] pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
05/03/2006CN1768058A Imidazopyridine derivatives as melanocortin receptor agonists.
05/03/2006CN1768056A Chromenone indoles.
05/03/2006CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
05/03/2006CN1768053A Pyrazole compounds.
05/03/2006CN1768051A Substituted pyrazoles
05/03/2006CN1768050A Benzopyran compounds useful for treating inflammatory conditions
05/03/2006CN1768049A 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors
05/03/2006CN1768043A 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders.
05/03/2006CN1768041A Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
05/03/2006CN1768040A Isoquinoline-5-sulfonic acid amides as inhibitors of AKT (protein kinase B)
05/03/2006CN1768037A Chemical compounds.
05/03/2006CN1768036A Indolone-acetamide derivatives, processes for preparing them and their uses
05/03/2006CN1768035A Anti-obesity agent
05/03/2006CN1768034A Nover diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use
05/03/2006CN1768031A Novel hydroxamates as therapeutic agents
05/03/2006CN1767856A Pharmaceutical compositions for hepatitis C viral protease inhibitors
05/03/2006CN1767855A Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist
05/03/2006CN1767844A Rosmarinic acid composition
05/03/2006CN1767838A Biocompatible dialysis fluids containing icodextrins
05/03/2006CN1767837A Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 for immune activation or prevention and treatment of cancer and the preparation method thereof
05/03/2006CN1767836A Parenteral formulation of mycophenolic acid, a salt or prodrug thereof.
05/03/2006CN1767835A Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
05/03/2006CN1767834A Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
05/03/2006CN1767833A Use of carbamazepine derivatives for the treatment of agitation in dementia patients
05/03/2006CN1767832A Combinations comprising anti-epileptic drugs for the treatment of neurological disorders.
05/03/2006CN1767831A Pharmaceutical formulations containing methylnaltrexone
05/03/2006CN1767830A The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome
05/03/2006CN1767829A 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors.
05/03/2006CN1767828A Medicinal composition
05/03/2006CN1767827A Remedy and/or preventive for lung diseases
05/03/2006CN1767826A Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases.
05/03/2006CN1767825A Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
05/03/2006CN1767824A Photostabilized topical formulations of KETOPROFEN
05/03/2006CN1767823A Asthma and allergic inflammation modulators